Rasika Kalamegham

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

Fred R. Hirsch, Abigail McElhinny, Dave Stanforth et al. · Journal of Thoracic Oncology · 2016 · 1.2K citations · Full text

Cancer Immunosurveillance, Advanced Lung Disease, Medicine +8

Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing

Wenming Xiao, Luyao Ren, Zhong Chen et al. · Nature Biotechnology · 2021 · 195 citations · Full text

Sequencing, Engineering, Somatic Variant +14

Current Status of Companion and Complementary Diagnostics: Strategic Considerations for Development and Launch

Heleen Scheerens, A Malong, K Bassett et al. · Clinical and Translational Science · 2017 · 117 citations · Full text

Adaptive Design for a Confirmatory Basket Trial in Multiple Tumor Types Based on a Putative Predictive Biomarker

RA Beckman, Zoran Antonijevic, Rasika Kalamegham et al. · Clinical Pharmacology & Therapeutics · 2016 · 66 citations

Statistical Design and Considerations of a Phase 3 Basket Trial for Simultaneous Investigation of Multiple Tumor Types in One Study

Cong Chen, Xiaoyun Li, Shuai Yuan et al. · Statistics in Biopharmaceutical Research · 2016 · 56 citations